For the quarter ending 2025-12-31, COHR had -$24,104K decrease in cash & cash equivalents over the period. -$95,698K in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Net earnings | 143,814 | 225,196 | -98,111 | 1,765 |
| Depreciation | 55,511 | 52,983 | 62,776 | 59,407 |
| Amortization | 70,508 | 69,446 | 72,047 | 87,163 |
| Share-based compensation expense | 42,768 | 44,134 | 43,590 | 40,960 |
| Amortization of debt issuance costs | 7,347 | -391 | - | 5,243 |
| Non-cash restructuring and impairment charges | 10,770 | 9,872 | 140,912 | - |
| Non-cash restructuring charges | - | - | - | 24,632 |
| Amortization of discount on convertible debt and debt issuance costs | - | - | 19,774 | - |
| Loss on disposal of property, plant and equipment | -21 | -127 | -670 | -45 |
| Unrealized gains on foreign currency remeasurements and transactions | 4,257 | 4,226 | -26,281 | -16,370 |
| Earnings from equity investments | 61 | 215 | 690 | 125 |
| Deferred income taxes | 10,601 | -83,665 | -7,333 | -28,483 |
| Gain on sale of business | 0 | 115,211 | - | - |
| Gain on sale of equity investment | 14,812 | 6,726 | - | - |
| Loss on debt extinguishment | 0 | -3,056 | 0 | - |
| Accounts receivable | 24,759 | 66,628 | 4,329 | 127,266 |
| Inventories | 202,253 | 219,120 | 105,427 | 30,780 |
| Accounts payable | 100,214 | 105,357 | 89,094 | 80,243 |
| Contract liabilities | -234 | -8,022 | -1,437 | 14,464 |
| Income taxes | -66,399 | 37,221 | -19,944 | -10,995 |
| Accrued compensation and benefits | 32,644 | -48,206 | 33,086 | 28,798 |
| Other operating net assets (liabilities) | 98,589 | -40,796 | 62,012 | -1,516 |
| Net cash provided by operating activities | 57,900 | 45,955 | 130,284 | 162,957 |
| Additions to property, plant & equipment | 153,598 | 103,946 | 131,350 | 111,819 |
| Purchases of businesses, net of cash acquired | - | - | 0 | - |
| Proceeds from sale of equity investment | 21,896 | 9,635 | - | - |
| Proceeds from the sale of business | - | - | 0 | 0 |
| Proceeds from the sale of business, net of fees | -5,330 | 391,127 | - | - |
| Other investing activities | 1,499 | 18 | -659 | -88 |
| Net cash provided by (used in) investing activities | -138,531 | 296,798 | -130,691 | -111,731 |
| Proceeds from issuance of series b preferred shares | - | - | 0 | - |
| Sale of shares to noncontrolling interests | - | - | 0 | 0 |
| Proceeds from borrowing of credit facility-Term ALoan Facility | 0 | 1,250,000 | 0 | - |
| Proceeds from borrowing of credit facility-Term BLoan Facility | 0 | 3,267 | 0 | - |
| Proceeds from borrowings of revolving credit facilities | 224,669 | 88,908 | 17,867 | 35,862 |
| Payments on existing debt | 8,620 | 1,650,805 | 50,980 | 135,796 |
| Payments on borrowings under revolving credit facilities | 174,288 | 77,046 | 17,513 | 34,148 |
| Payments on convertible notes | - | - | 0 | - |
| Debt issuance costs | 559 | 8,542 | 0 | - |
| Equity issuance costs | - | - | 0 | 0 |
| Proceeds from exercises of stock options and purchases of stock under employee stock purchase plan | 8,809 | 21,278 | 2,108 | 18,228 |
| Payments in satisfaction of employees' minimum tax obligations | 7,173 | 37,443 | 5,053 | 3,897 |
| Cash dividends paid | 0 | 11,438 | 11,438 | - |
| Other financing activities | 220 | 335 | -229 | -264 |
| Net cash used in financing activities | 43,058 | -421,486 | -65,238 | -120,015 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 13,469 | -1,280 | 72,528 | 26,177 |
| Net decrease in cash, cash equivalents, and restricted cash | -24,104 | -80,013 | 6,883 | -42,612 |
| Cash and cash equivalents at beginning of period | 1,552,900 | 1,632,913 | 1,626,030 | 1,668,642 |
| Cash and cash equivalents at end of period | 1,528,796 | 1,552,900 | 1,632,913 | 1,626,030 |
COHERENT CORP. (COHR)
COHERENT CORP. (COHR)